Literature DB >> 7640240

Limitations of the death certificate only index as a measure of incompleteness of cancer registration.

H Brenner1.   

Abstract

The death certificate only (DCO) index, which quantifies the proportion of patients for whom the death certificate provides the only notification to the registry, is a widely used measure of incompleteness of population-based cancer registration. This paper provides an algebraic assessment and a quantitative illustration of the relationship between the DCO index and incompleteness of cancer registration. It is shown that the relationship between the DCO index and incompleteness of registration is strongly dependent on the case fatality rate and the misclassification rates of cancer deaths among unregistered patients. Therefore, the DCO index is a very poor indicator of incompleteness. Similar limitations apply to the DCN index (proportion of cases first notified by death certificate), which has been proposed as an alternative measure of incompleteness.

Entities:  

Mesh:

Year:  1995        PMID: 7640240      PMCID: PMC2034008          DOI: 10.1038/bjc.1995.363

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  The relative survival rate: a statistical methodology.

Authors:  F EDERER; L M AXTELL; S J CUTLER
Journal:  Natl Cancer Inst Monogr       Date:  1961-09

2.  Estimation of completeness and adjustment of age-specific and age-standardized incidence rates.

Authors:  S G Hilsenbeck; C Kurucz; R C Duncan
Journal:  Biometrics       Date:  1992-12       Impact factor: 2.571

3.  Availability and completeness of cancer registration worldwide.

Authors:  K Shanmugaratnam
Journal:  Recent Results Cancer Res       Date:  1989

4.  Ascertainment corrected rates: applications of capture-recapture methods.

Authors:  D J McCarty; E S Tull; C S Moy; C K Kwoh; R E LaPorte
Journal:  Int J Epidemiol       Date:  1993-06       Impact factor: 7.196

Review 5.  Registry evaluation methods: a review and case study.

Authors:  J Goldberg; H M Gelfand; P S Levy
Journal:  Epidemiol Rev       Date:  1980       Impact factor: 6.222

6.  Cancer survival statistics; international data.

Authors:  W P Logan
Journal:  World Health Stat Q       Date:  1978

7.  Completeness of cancer registration in Limburg, The Netherlands.

Authors:  L J Schouten; P Höppener; P A van den Brandt; J A Knottnerus; J J Jager
Journal:  Int J Epidemiol       Date:  1993-06       Impact factor: 7.196

8.  Undernotification of diagnosed cancer cases to the Stockholm Cancer Registry.

Authors:  B Mattsson; L E Rutqvist; A Wallgren
Journal:  Int J Epidemiol       Date:  1985-03       Impact factor: 7.196

9.  Variations in the level of reporting by hospitals to a regional cancer registry.

Authors:  L S Freedman
Journal:  Br J Cancer       Date:  1978-05       Impact factor: 7.640

10.  The completeness of cancer registration in England: an assessment from the Oxford-FPA contraceptive study.

Authors:  L Villard-Mackintosh; M P Coleman; M P Vessey
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

View more
  3 in total

1.  Comparability, diagnostic validity and completeness of Nigerian cancer registries.

Authors:  B J S al-Haddad; Elima Jedy-Agba; Emmanuel Oga; E R Ezeome; Christopher C Obiorah; Michael Okobia; J Olufemi Ogunbiyi; Cornelius Ozobia Ukah; Abidemi Omonisi; A M E Nwofor; Festus Igbinoba; Clement Adebamowo
Journal:  Cancer Epidemiol       Date:  2015-04-08       Impact factor: 2.984

2.  Completeness of cancer registration: a new method for routine use.

Authors:  J Bullard; M P Coleman; D Robinson; J M Lutz; J Bell; J Peto
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

3.  Cancer has overtaken cardiovascular disease as the commonest cause of death in Scottish type 2 diabetes patients: A population-based study (The Ayrshire Diabetes Follow-up Cohort study).

Authors:  Andrew Collier; Carron Meney; Mario Hair; Lyall Cameron; James G Boyle
Journal:  J Diabetes Investig       Date:  2019-07-25       Impact factor: 4.232

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.